Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Neuro42
AddedFeb 15, 2024
UpdatedJun 18, 2026
Neuro42

Neuro42

Series B

neuro42: Innovating advanced MRI tech for diagnosing and treating neurological conditions.

HQ
Oakland, CA, US
Founded
2020
Overview
Compare
Fundraising
Employees

Neuro42 is dedicated to developing and commercializing advanced MRI technology for the diagnosis and image-guided interventions of neurological diseases and conditions. Their mission is to revolutionize neurological healthcare by providing cutting-edge imaging solutions that enhance diagnostic accuracy and treatment efficacy.

Named one of the Top 10 Great Companies to Work for in 2023, Neuro42 has made significant strides in the medical imaging field. Their innovative technology has the potential to transform how neurological conditions are diagnosed and treated, making a substantial impact on patient care and medical outcomes.

Neuro42 - Similar Companies

BrainHealth logo

BrainHealth

NeuroFieldz logo

NeuroFieldz

neurofieldz.com

Alpha-Mri logo

Alpha-Mri

SpinTech logo

SpinTech

Neuron23 logo

Neuron23

Neuroview Technology logo

Neuroview Technology

neuroviewtech.com

NeuroVision Imaging logo

NeuroVision Imaging

neurovision.com

NeuroBionics logo

NeuroBionics

Neurogami Medical logo

Neurogami Medical

Novela Neurotech logo

Novela Neurotech

novelaneuro.com

nQ Medical logo

nQ Medical

NeurInsight logo

NeurInsight

neurinsight.com

Neurovia logo

Neurovia

Neuraly logo

Neuraly

neuralymed.com

Real Time Imaging Technologies logo

Real Time Imaging Technologies

Neuro42 - Quick Facts

Who are Neuro42's competitors?

Companies similar to Neuro42 include BrainHealth, NeuroFieldz, Alpha-Mri and SpinTech.

When was Neuro42 founded?

Neuro42 was founded in 2020.

Where is Neuro42's headquarters located?

Neuro42's headquarters is located in Oakland, CA, US.

How much has Neuro42 raised to-date?

As of Oct 5, 2023, Neuro42 has raised a total of $12.8M (USD).

How many employees does Neuro42 have?

Neuro42 has 26 employees as of Feb 4, 2024.

Neuro42 - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • Global
Revenue
  • Software
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
  • Medtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 8 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research